Publicaciones en las que colabora con Julián de la Torre Cisneros (117)

2024

  1. Slaying the “Troll of Transplantation”—new frontiers in cytomegalovirus management: A report from the CMV International Symposium 2023

    Transplant Infectious Disease, Vol. 26, Núm. 1

2023

  1. Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae

    American Journal of Transplantation, Vol. 23, Núm. 7, pp. 1022-1034

  2. Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)

    eClinicalMedicine, Vol. 57

2022

  1. Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021

    Transplant Infectious Disease, Vol. 24, Núm. 6

  2. Extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacterales bloodstream infection after solid organ transplantation: Recent trends in epidemiology and therapeutic approaches

    Transplant Infectious Disease, Vol. 24, Núm. 4

  3. Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 7, pp. 1996-2002

  4. Immunoguided Discontinuation of Prophylaxis for Cytomegalovirus Disease in Kidney Transplant Recipients Treated With Antithymocyte Globulin: A Randomized Clinical Trial

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 74, Núm. 5, pp. 757-765

  5. Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 5, pp. 1452-1460

  6. Recommendations for prevention of infection in systemic autoimmune rheumatic diseases

    Reumatologia Clinica, Vol. 18, Núm. 6, pp. 317-330

2021

  1. Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project)

    Transplant infectious disease : an official journal of the Transplantation Society, Vol. 23, Núm. 3, pp. e13520

  2. Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics

    Nature Communications, Vol. 12, Núm. 1

  3. Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study)

    Mycoses, Vol. 64, Núm. 11, pp. 1334-1345

  4. Invasive fusariosis in nonneutropenic patients, Spain, 2000-2015

    Emerging Infectious Diseases, Vol. 27, Núm. 1, pp. 26-35

  5. Microbiota-based markers predictive of development of Clostridioides difficile infection

    Nature Communications, Vol. 12, Núm. 1

  6. Molecular characterization of multidrug resistant Enterobacterales strains isolated from liver and kidney transplant recipients in Spain

    Scientific Reports, Vol. 11, Núm. 1

  7. Natural influenza infection produces a greater diversity of humoral responses than vaccination in immunosuppressed transplant recipients

    American Journal of Transplantation, Vol. 21, Núm. 8, pp. 2709-2718

  8. Oral decontamination with colistin plus neomycin in solid organ transplant recipients colonized by multidrug-resistant Enterobacterales: a multicentre, randomized, controlled, open-label, parallel-group clinical trial

    Clinical Microbiology and Infection, Vol. 27, Núm. 6, pp. 856-863

  9. Pretransplant CMV-Specific T-Cell Immunity But Not Dose of Antithymocyte Globulin Is Associated With Recovery of Specific Immunity After Kidney Transplantation

    The Journal of infectious diseases, Vol. 223, Núm. 7, pp. 1205-1213

  10. Propensity score and desirability of outcome ranking analysis of ertapenem for treatment of nonsevere bacteremic urinary tract infections due to extended-spectrum-beta-lactamase-producing enterobacterales in kidney transplant recipients

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 11

  11. Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study

    PLoS ONE, Vol. 16, Núm. 4 April